中国肺癌杂志2023，Vol.26Issue(9)：659-668,10.DOI:10.3779/j.issn.1009-3419.2023.101.26
PD-1单抗联合化疗与化疗治疗Ⅲ-Ⅳ期SMARCA4缺失型非小细胞肺癌的疗效评估及预后分析
Evaluation of Efficacy and Prognosis Analysis of Stage Ⅲ-Ⅳ SMARCA4-deficient Non-small Cell Lung Cancer Treated by PD-1 Immune Checkpoint Inhibitors plus Chemotherapy and Chemotherapy
摘要
关键词
肺肿瘤/SMARCA4/免疫检查点抑制剂/化疗/预后/Cox比例风险模型Key words
Lung neoplasms/SMARCA4/Immune checkpoint inhibitors/Chemotherapy/Prognosis/Cox propor-tional hazards models引用本文复制引用
王新娟,屠蒙,贾红霞,刘宏平,王琰,王一博,姜楠,卢春亚,张国俊..PD-1单抗联合化疗与化疗治疗Ⅲ-Ⅳ期SMARCA4缺失型非小细胞肺癌的疗效评估及预后分析[J].中国肺癌杂志,2023,26(9):659-668,10.基金项目
本研究受国家自然科学基金项目(No.81874042)和河南省呼吸疾病临床医学研究中心资助This study was supported by the grants from National Natural Science Foundation of China(No.81874042)(to Guo-jun ZHANG)and the Clinical Medical Research Center for Respiratory Diseases of Henan Province. （No.81874042）
